课题基金 / 基金详情

Expression of the HSPB2 and αB-crystallin genes located in a head-to-head manner

Expression of the HSPB2 and αB-crystallin genes located in a head-to-head manner
HSPB2 和 αB-晶状体蛋白基因的表达以头对头的方式定位
批准号:
10680654
负责人:
IWAKI Akiko
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

IWAKI Akiko的其他基金

相似基金

相关文献

中文摘要
翻译
此前,我们发现了α-晶体蛋白/小分子热休克蛋白家族中的一个新成员,并将其命名为HSPB2(基因组学,1997年)。HSPB2基因和αB-晶体蛋白基因是小分子热休克蛋白家族中的另一个成员,它们以头对头的方式排列,基因间序列长956bp,这为它们的表达提供了共享增强子元件的可能性。在这项研究中,我们检测了新发现的HSPB2基因的空间和时间表达模式,并与αB-晶体蛋白基因的表达模式进行了比较。此外,我们还研究了这两个基因在培养细胞和转基因小鼠中表达的调控机制。(1)Northern杂交和原位杂交结果表明,HSPB2基因在心脏和肌肉中表达,而在眼晶状体中不表达。虽然HSPB2mRNA的表达水平远低于αB-晶状体蛋白的表达水平,但它们在肌肉中表达的发育规律相似(准备阶段)。(2)两个基因在C2C12细胞和转基因小鼠中的功能启动子分析表明,肌肉特异的增强子元件存在竞争,存在于基因间隔区(准备)。(3)细胞外钾浓度过高时,αB-晶体蛋白在神经胶质细胞中积聚,而不是HSPB2.利用缺失和突变构建的功能启动子分析表明,在U-251MGKC中,热休克元件是αB-晶体蛋白基因转录激活所必需的。凝胶迁移率和抗体超移动分析表明,KCl2诱导热休克因子2的HSE结合活性,提示HSF2参与了KCl抑制胶质细胞αB-晶体蛋白基因表达的过程(已提交)。
英文摘要
Previously we identified a new member of the α-crystallin/small heat shock protein (HSP) family and named it HSPB2 (Genomics, 1997). The HSPB2 gene and the αB-crystallin gene, another member of the small HSP family, are arranged in a head-to-head manner with an intergenic sequence of 956 bp, raising a possibility of shared enhancer elements for their expression. In this study we examined spatial and temporal expression patterns of the newly identified HSPB2 gene and compared with that of the αB-crystallin gene. Furthermore, we investigated the regulatory mechanisms of expression of the two genes in cultured cells and transgenic mice. (1) Northern blotting and in situ hybridization revealed that the HSPB2 gene is expressed in heart and muscles but not in eye lens. Although the level of HSPB2 mRNA was much lower than that of αB-crystallin, the developmental profiles of their expression were similar in muscles (in preparation). (2) Functional promoter analysis of the two genes in C2C12 cells and transgenic mice revealed a competition of muscle specific enhancer elements, which arc present in the intergenic region (in preparation). (3) αB-Crystallin, but not HSPB2, accumulates in glial cells in response to high extracellular potassium concentrations. Functional promoter analysis using deletion and mutation constructs revealed that the heat shock element (HSE) is essential for transcriptional activation of the αB-crystallin gene by KCl in U-251MG.Gel mobility shift and antibody supershift assays showed that KCl induces the HSE-binding activity of heat shock factor 2 (HSF2), suggesting that HSF2 is involved in KCl-depedent increases in αB-crystallin mRNA in glial cells (submitted).
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Sasaki, A., et al.: "Two autopsy cases with Pelizaeus-Merzbacher disease phenotype of adult onset, without mutation of proteolipid protein gene."Acta.Neuropathol.. 99. 7-13 (2000)
Sasaki, A., et al.:“两例尸检病例,具有成人发病的 Pelizaeus-Merzbacher 病表型,无蛋白脂质蛋白基因突变。”Acta.Neuropathol.. 99. 7-13 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Molecular analysis of the CNTN4 knockout mice
  • 批准号:
    21590359
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    IWAKI Akiko
  • 依托单位:
Molecular Pathology of the dysmyelinating diseases and generation of the model animals
  • 批准号:
    06680741
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.47万
  • 财政年份:
    1994
  • 负责人:
    IWAKI Akiko
  • 依托单位:
国内基金
海外基金
α-crystallin 对低温冷应激下晶状体细胞代谢 异常的调控及其分子机制研究
  • 批准号:
    Q24H120012
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吴晶
  • 依托单位:
淀粉样蛋白病理性聚集及αB-crystallin内源性蛋白对其调控机制的分子模拟研究
  • 批准号:
    11904189
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2019
  • 负责人:
    孙运祥
  • 依托单位:
一种小分子热休克蛋白αB-Crystallin肠道抑炎作用及其在炎症性肠病中的调控机制研究
  • 批准号:
    81873547
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2018
  • 负责人:
    杜鹏
  • 依托单位:
αB-Crystallin在热应激导致心肌细胞非特异性损伤中的保护作用及其分子机制
  • 批准号:
    31602027
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2016
  • 负责人:
    唐姝
  • 依托单位: